PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.\', \'Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. amir.horowitz@mssm.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1158/2159-8290.CD-21-0613
?:hasPublicationType
?:journal
  • Cancer discovery
is ?:pmid of
?:pmid
?:pmid
  • 34344757
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.996
?:rankingScore_hIndex
  • 98
is ?:relation_isRelatedTo_publication of
?:title
  • Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all